Monday
November 16, 2026
12:00 pm – 1:00 pm
Breakout
Country Roundtable — Brazil
Brazil stands in a category of its own in Latin American clinical research. ANVISA operates as a distinct regulatory authority with its own frameworks and requirements, and the landmark 2024 legislation on research involving human subjects brought unprecedented legal clarity to the conduct of trials in the country — triggering a measurable increase in study activity, particularly in early-phase research. This roundtable explores what is driving Brazil’s momentum, what it means for sites operating there today, and how to maximize the opportunity ahead.